BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2553627)

  • 1. Studies on the oncogenic potential of Epstein-Barr-virus (EBV)-infected B cells in AIDS-related disorders.
    Roncella S; Caretto P; Forni G; Cutrona G; Verde A; Ramarli D; di Celle PF; Foà R; Sessarego M; Pistoia V
    Int J Cancer Suppl; 1989; 4():78-82. PubMed ID: 2553627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the potential malignancy of Epstein-Barr virus (EBV)-infected B cells in AIDS-related disorders.
    Roncella S; Caretto P; Forni G; Cutrona G; Verde A; Ramarli D; de Celle PF; Foá R; Sessarego M; Pistoia V
    Cancer Detect Prev; 1990; 14(3):325-9. PubMed ID: 2167168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of inflammatory cytokines by Epstein-Barr virus (EBV)-infected lymphoblastoid cell lines spontaneously originated from the peripheral blood of patients with human immunodeficiency virus (HIV) infection.
    Roncella S; Baldi L; Cutrona G; Viale M; Rizzo F; Gasco M; Ferrarini M; Pistoia V
    Clin Immunol Immunopathol; 1995 Nov; 77(2):162-71. PubMed ID: 7586723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of EBV-positive lymphoblastoid cell lines obtained from HIV seropositive patients with or without lymphomas.
    Roncella S; Di Celle PF; Cutrona G; Carbone A; Sessarego M; Dodi F; Foa R; Rowe M; Ferrarini M
    Leukemia; 1992; 6 Suppl 3():12S-14S. PubMed ID: 1318463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro establishment of tumorigenic human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Takahashi T; Kawabe T; Okazaki Y; Itoh C; Noda K; Tajima M; Satoh M; Goto M; Mitsui Y; Tahara H; Ide T; Furuichi Y; Sugimoto M
    DNA Cell Biol; 2003 Nov; 22(11):727-35. PubMed ID: 14659045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection of Epstein-Barr virus-transformed lymphoblastoid B cells by the human immunodeficiency virus: evidence for a persistent and productive infection leading to B cell phenotypic changes.
    De Rossi A; Roncella S; Calabro ML; D'Andrea E; Pasti M; Panozzo M; Mammano F; Ferrarini M; Chieco-Bianchi L
    Eur J Immunol; 1990 Sep; 20(9):2041-9. PubMed ID: 2170147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and phenotypical changes in EBV positive lymphoblastoid cells infected by HIV-1.
    De Rossi A; Calabro ML; D'Andrea E; Panozzo M; Saggiori D; Mammano F; Roncella S; Ferrarini M; Chieco-Bianchi L
    Leukemia; 1992; 6 Suppl 3():38S-40S. PubMed ID: 1318475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
    Sugimoto M; Tahara H; Ide T; Furuichi Y
    Cancer Res; 2004 May; 64(10):3361-4. PubMed ID: 15150084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls.
    Ounanian A; Guilbert B; Seigneurin JM
    Mech Ageing Dev; 1992 Mar; 63(1):105-16. PubMed ID: 1318479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
    Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
    Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered HIV expression and EBV-induced transformation in coinfected PBLs and PBL subpopulations.
    Henderson EE; Yang JY; Zhang RD; Bealer M
    Virology; 1991 May; 182(1):186-98. PubMed ID: 1708929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
    Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
    Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 and c-Myc co-operate in the Epstein-Barr virus-immortalized human B-cell line GM607 but do not confer tumorigenicity.
    Tomlin JL; Guinn BA; Penn LZ; Berinstein NL
    Leuk Lymphoma; 2005 Apr; 46(4):581-92. PubMed ID: 16019487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus activates c-myc and Epstein-Barr virus in human B lymphocytes.
    Astrin SM; Laurence J
    Ann N Y Acad Sci; 1992 May; 651():422-32. PubMed ID: 1318011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
    Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
    Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmacytoid differentiation of Epstein-Barr virus-transformed B cells in vivo is associated with reduced expression of viral latent genes.
    Rochford R; Hobbs MV; Garnier JL; Cooper NR; Cannon MJ
    Proc Natl Acad Sci U S A; 1993 Jan; 90(1):352-6. PubMed ID: 8380497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease.
    Dolcetti R; Quaia M; Gloghini A; De Re V; Zancai P; Cariati R; Babuin L; Cilia AM; Rizzo S; Carbone A; Boiocchi M
    Int J Cancer; 1999 Jan; 80(2):240-9. PubMed ID: 9935206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes.
    Laurence J; Astrin SM
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7635-9. PubMed ID: 1652756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.